An interventional study of the mandible first and the maxilla first in Class III Malocclusion, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 16 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-10-20.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
The investigator will assess the inverted sequence approach in the treatment of class III patient undergoing bimaxillary orthognathic surgery
The investigator will compare the maxillary stability in class III orthognathic patients undergoing bimaxillary surgery by two surgical approaches ; the mandible-first (intervention) and the maxilla-first (control)
Exclusion Criteria:
the maxillary osteotomy is going to be done and fixed first
Procedure: the maxilla first
the mandibular osteotomy is going to be done and fixed first
Procedure: the mandible first
the mandible osteotomy is going to be done and fixed first
Also known as: the inverted sequence
the maxilla osteotomy is going to be done and fixed first
Also known as: the regular sequence
the change in maxilla stability
to assess the change in maxillary stability on cone beam CT obtained immediately and 6 month postoperative. the measuring unit is millimeter
Time frame: 6 months
Patient satisfaction
"the quality of life questionnaire" describes the patient's satisfaction during the entire treatment period which is done through a questionnaire answered by the patient through a score between 0-10 the measuring unit is numerical
Time frame: 6 month
Documents are hosted by the registry — open the source record to download them.
Plan to share: No — after the completion of my research i will publish the data in an international journal
This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cairo University